Eckert & Ziegler and IBt to consolidate Implant Businesses

Berlin, (PresseBox) - Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE 0005659700) and IBt s.a. have reached an agreement about the consolidation of their respective Businesses for Prostate Cancer Implants and executed a Share Contribution Agreement, in which Eckert & Ziegler sells its Implant Business to IBt with immediate effect in exchange for 6.75 million IBt shares. As a result, Eckert & Ziegler will become IBt s largest shareholder, owning about 40% of all rights to dividends and other economic benefits, and close to 30% of the voting rights in IBt s shareholder meeting. The difference in the two ratios is due to the existence of so-called Beneficiary Shares, which only convey voting rights in the shareholder meeting, but not to dividends.

Further details are provided in a press release which is available on the company s homepage.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.